AKYA250117P12500
- 0.00
- 0.000.00%
Akoya Biosciences Newsroom
BTIG Maintains Akoya Biosciences(AKYA.US) With Hold Rating
Hold Rating Suggested Amid Acquisition Uncertainties and Growth Concerns for Akoya Biosciences
J.P. Morgan Maintains Akoya Biosciences(AKYA.US) With Hold Rating
CCORF Downgrades Akoya Biosciences(AKYA.US) to Hold Rating, Maintains Target Price $3.5
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Cuts Target Price to $3
Morgan Stanley Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Maintains Target Price $3
Akoya Biosciences Is Maintained at Buy by Canaccord Genuity
Akoya Biosciences Analyst Ratings
Piper Sandler Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Maintains Target Price $4
Craig-Hallum Downgrades Akoya Biosciences(AKYA.US) to Hold Rating, Announces Target Price $5
Piper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)
CCORF Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Cuts Target Price to $3.5
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating
Craig-Hallum Sticks to Its Buy Rating for Akoya Biosciences (AKYA)
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating, Announces Target Price $7
Craig-Hallum Maintains Akoya Biosciences(AKYA.US) With Buy Rating
Craig-Hallum Reaffirms Their Buy Rating on Akoya Biosciences (AKYA)